Table 2.
Mpox stigma (91.6%) | Mpox sexual stigma (91.6%), Vulnerability to mpox stigma due to visibility (75.0%), Mpox stigma similarities to HIV stigma (66.7%), Mpox-related homophobia (29.2%), Mpox stigma deterring PrEP (54.1%) |
Mpox vaccine availability (70.8%) | Needs for more mpox vaccines (70.8%), governments not prioritizing mpox vaccines (66.7%), Mpox vaccine unavailability facilitating medical mistrust (37.5%), concerns about reduced vaccine dose for rationing (20.8%), Lost opportunities for PrEP promotion alongside mpox vaccines (20.8%) |
Mpox vaccine hesitancy (50.0%) | Mpox vaccine hesitancy (50.0%), mpox vaccine-related sexual stigma (37.5%), exhaustion with medical interventions for SMM sex (16.7%) |
Parentheses after each theme contain the percentage of participant interviews where that theme was observed.